TY - JOUR
T1 - Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension
AU - Bekedam, F. T.
AU - Goumans, M. J.
AU - Bogaard, H. J.
AU - de Man, F. S.
AU - Llucià-Valldeperas, A.
N1 - Funding Information: This research was financially supported by the Netherlands Organization for Scientific Research: NWO-VIDI num. 917.18.338 (F.S. de Man). The work was also funded by the Dutch Heart Foundation Dekker senior post-doc grant num. 2018T059 (F.S. de Man), and the Netherlands CardioVascular Research Initiative: CVON-2017-10 DOLPHIN-GENESIS (F.S. de Man, H.J. Bogaard and MJ Goumans), and CVON-2018-29 PHAEDRA-IMPACT (A. Llucià-Valldeperas, F.T. Bekedam, H.J. Bogaard, M.J. Goumans and F.S. de Man). Figures were created using BioRender. Funding Information: This research was financially supported by the Netherlands Organization for Scientific Research : NWO-VIDI num. 917.18.338 (F.S. de Man). The work was also funded by the Dutch Heart Foundation Dekker senior post-doc grant num. 2018T059 (F.S. de Man), and the Netherlands CardioVascular Research Initiative : CVON-2017-10 DOLPHIN-GENESIS (F.S. de Man, H.J. Bogaard and MJ Goumans), and CVON-2018-29 PHAEDRA-IMPACT (A. Llucià-Valldeperas, F.T. Bekedam, H.J. Bogaard, M.J. Goumans and F.S. de Man). Figures were created using BioRender. Publisher Copyright: © 2023
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Right ventricular fibrosis is a stress response, predominantly mediated by cardiac fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory cytokines, pro-fibrotic growth factors and mechanical stimulation. Activation of fibroblasts results in the induction of various molecular signaling pathways, most notably the mitogen-activated protein kinase cassettes, leading to increased synthesis and remodeling of the extracellular matrix. While fibrosis confers structural protection in response to damage induced by ischemia or (pressure and volume) overload, it simultaneously contributes to increased myocardial stiffness and right ventricular dysfunction. Here, we review state-of-the-art knowledge of the development of right ventricular fibrosis in response to pressure overload and provide an overview of all published preclinical and clinical studies in which right ventricular fibrosis was targeted to improve cardiac function.
AB - Right ventricular fibrosis is a stress response, predominantly mediated by cardiac fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory cytokines, pro-fibrotic growth factors and mechanical stimulation. Activation of fibroblasts results in the induction of various molecular signaling pathways, most notably the mitogen-activated protein kinase cassettes, leading to increased synthesis and remodeling of the extracellular matrix. While fibrosis confers structural protection in response to damage induced by ischemia or (pressure and volume) overload, it simultaneously contributes to increased myocardial stiffness and right ventricular dysfunction. Here, we review state-of-the-art knowledge of the development of right ventricular fibrosis in response to pressure overload and provide an overview of all published preclinical and clinical studies in which right ventricular fibrosis was targeted to improve cardiac function.
KW - Fibrosis
KW - Myocardial stiffness
KW - Right ventricle
KW - Therapy, cardiac fibroblast
KW - Ventricular dysfunction
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150893445&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36940790
U2 - https://doi.org/10.1016/j.pharmthera.2023.108389
DO - https://doi.org/10.1016/j.pharmthera.2023.108389
M3 - Review article
C2 - 36940790
SN - 0163-7258
VL - 244
JO - Pharmacology and Therapeutics
JF - Pharmacology and Therapeutics
M1 - 108389
ER -